Afutuzumab Market

Afutuzumab, more commonly known as obinutuzumab is a humanized type II monoclonal antibody against CD20 (coded for by MS4A1 for the treatment of Chronic lymphocytic leukemia, CLL. It may have more direct antibody-dependent cell-mediated cytotoxicity and possibly more direct cytotoxicity than previously available type I antibodies such as rituximab and ofatumumab which have more complement-dependent cytotoxicity.
Afutuzumab Market contains market size and forecasts of Afutuzumab in global, including the following market information:
Global Afutuzumab Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Afutuzumab Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Afutuzumab companies in 2021 (%)
The global Afutuzumab market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Patent Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Afutuzumab include BOC Sciences, Carbosynth, Roche Group, TargetMol Chemicals, Wonda Science, Absin Bioscience, Chunchuang (Wuhan) Technology, Hubei Kele Fine Chemical and Jiangxi Ruiweier Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Afutuzumab manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Afutuzumab Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Afutuzumab Market Segment Percentages, by Type, 2021 (%)
Patent
Generic
Global Afutuzumab Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Afutuzumab Market Segment Percentages, by Application, 2021 (%)
Chronic Lymphocytic Leukemia
Follicular Lymphoma
Global Afutuzumab Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Afutuzumab Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Afutuzumab revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Afutuzumab revenues share in global market, 2021 (%)
Key companies Afutuzumab sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Afutuzumab sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BOC Sciences
Carbosynth
Roche Group
TargetMol Chemicals
Wonda Science
Absin Bioscience
Chunchuang (Wuhan) Technology
Hubei Kele Fine Chemical
Jiangxi Ruiweier Biotechnology
Qingdao Jieshikang Biotechnology
Shanghai Biochempartner
Shanghai Macklin Biochemical
Shanghai Qiming Biotechnology
Shanghai Saimai Biotechnology
Shanghai Shize Biological Technology
Shanghai Yifei Biotechnology
Shanghai Yu'ang Chemical
Tianmen Hengchang Chemical
Wuhan Sunrise Technology Development
Wuhan Yingnuo Pharmaceutical Technology